Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> Childhood Immunization Rebounds – But Still Below Pre-Pandemic Levels 18/07/2023 Elaine Ruth Fletcher Routine childhood immuniaztions rebounded in 2022 from the set-backs of the COVID pandemic. But coverage still fell short of pre-COVID numbers in 2019, with 20.5 million children missing out on one or more routine vaccines last year as compared to 18.4 million in 2019. The new data is contained in a report published jointly Tuesday […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> 18 Million Doses of Malaria Vaccine Due to Be Distributed Soon to 12 Countries in Africa 05/07/2023 Megha Kaveri Twenty-two months after the world’s first malaria vaccine RTS,S was approved by the World Health Organization (WHO), 12 countries in Africa will soon receive 18 million doses. A second, arguably more efficient, vaccine against malaria is currently in the queue for WHO approval. Meanwhile, distribution of the 18 million RTS,S doses is to be carried […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Lining Up Realistic Solutions if the ‘Holy Grail’ of the Pandemic Accord Fails 21/07/2023 Kerry Cullinan With the fate and nature of the pandemic accord currently being negotiated by World Health Organization (WHO) member states still uncertain, global health experts are calling for “realistic” backup plans to protect the world against the next pandemic. “We need an ambitious but implementable pandemic accord – that is the Holy Grail,” Javier Guzman, Director […] Continue reading -> Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> Childhood Immunization Rebounds – But Still Below Pre-Pandemic Levels 18/07/2023 Elaine Ruth Fletcher Routine childhood immuniaztions rebounded in 2022 from the set-backs of the COVID pandemic. But coverage still fell short of pre-COVID numbers in 2019, with 20.5 million children missing out on one or more routine vaccines last year as compared to 18.4 million in 2019. The new data is contained in a report published jointly Tuesday […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> 18 Million Doses of Malaria Vaccine Due to Be Distributed Soon to 12 Countries in Africa 05/07/2023 Megha Kaveri Twenty-two months after the world’s first malaria vaccine RTS,S was approved by the World Health Organization (WHO), 12 countries in Africa will soon receive 18 million doses. A second, arguably more efficient, vaccine against malaria is currently in the queue for WHO approval. Meanwhile, distribution of the 18 million RTS,S doses is to be carried […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> Childhood Immunization Rebounds – But Still Below Pre-Pandemic Levels 18/07/2023 Elaine Ruth Fletcher Routine childhood immuniaztions rebounded in 2022 from the set-backs of the COVID pandemic. But coverage still fell short of pre-COVID numbers in 2019, with 20.5 million children missing out on one or more routine vaccines last year as compared to 18.4 million in 2019. The new data is contained in a report published jointly Tuesday […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> 18 Million Doses of Malaria Vaccine Due to Be Distributed Soon to 12 Countries in Africa 05/07/2023 Megha Kaveri Twenty-two months after the world’s first malaria vaccine RTS,S was approved by the World Health Organization (WHO), 12 countries in Africa will soon receive 18 million doses. A second, arguably more efficient, vaccine against malaria is currently in the queue for WHO approval. Meanwhile, distribution of the 18 million RTS,S doses is to be carried […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Childhood Immunization Rebounds – But Still Below Pre-Pandemic Levels 18/07/2023 Elaine Ruth Fletcher Routine childhood immuniaztions rebounded in 2022 from the set-backs of the COVID pandemic. But coverage still fell short of pre-COVID numbers in 2019, with 20.5 million children missing out on one or more routine vaccines last year as compared to 18.4 million in 2019. The new data is contained in a report published jointly Tuesday […] Continue reading -> Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> 18 Million Doses of Malaria Vaccine Due to Be Distributed Soon to 12 Countries in Africa 05/07/2023 Megha Kaveri Twenty-two months after the world’s first malaria vaccine RTS,S was approved by the World Health Organization (WHO), 12 countries in Africa will soon receive 18 million doses. A second, arguably more efficient, vaccine against malaria is currently in the queue for WHO approval. Meanwhile, distribution of the 18 million RTS,S doses is to be carried […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Agreement on TB Drug is ‘Stop Gap’ That Excludes High-Burden Countries in Eastern Europe and Central Asia 14/07/2023 Kerry Cullinan The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading -> 18 Million Doses of Malaria Vaccine Due to Be Distributed Soon to 12 Countries in Africa 05/07/2023 Megha Kaveri Twenty-two months after the world’s first malaria vaccine RTS,S was approved by the World Health Organization (WHO), 12 countries in Africa will soon receive 18 million doses. A second, arguably more efficient, vaccine against malaria is currently in the queue for WHO approval. Meanwhile, distribution of the 18 million RTS,S doses is to be carried […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
18 Million Doses of Malaria Vaccine Due to Be Distributed Soon to 12 Countries in Africa 05/07/2023 Megha Kaveri Twenty-two months after the world’s first malaria vaccine RTS,S was approved by the World Health Organization (WHO), 12 countries in Africa will soon receive 18 million doses. A second, arguably more efficient, vaccine against malaria is currently in the queue for WHO approval. Meanwhile, distribution of the 18 million RTS,S doses is to be carried […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
TB Vaccine Candidate Receives $550M Boost for Phase 3 Trial 29/06/2023 Megha Kaveri A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading -> The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Gambia Mandates Pre-shipment Quality Testing for All Medicines Exported from India 28/06/2023 Megha Kaveri The Gambia has mandated pre-shipment quality testing on all pharmaceutical products exported from India. The requirement will come into effect on 1 July 2023. It can be understood as an after-effect of last year’s scandal whereby India-manufactured cough syrups allegedly claimed the lives of 66 children in The Gambia in 2022 . Following the episode, […] Continue reading -> Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Medicines Patent Pool Announces Licenses for Generic COVID-19 Antiviral 27/06/2023 Stefan Anderson The Medicines Patent Pool (MPP) announced sublicensing agreements with seven manufacturers to produce and distribute generic versions of Japanese pharmaceutical company Shinogi’s COVID-19 antiviral treatment in 117 low- and middle-income countries. Ensitrelvir is an oral antiviral currently only approved in Japan under the country’s emergency regulatory approval system. The drug is being evaluated under a […] Continue reading -> Posts navigation Older postsNewer posts